This study examined the effect of GnRH-antagonist 
Introduction
Since the early reports that hypophysectomy suppressed spermatogenesis in rats (Smith, 1930) and monkeys (Smith, 1944) , numerous studies have failed to resolve major issues in the hormonal regulation of spermatogenesis, particularly the roles of the major endocrine regulators: FSH al, 1996; Sharpe, 1994) . While spermatogenesis has been reported in mice lacking the FSH ß gene (Kumar et al, 1997) and in men with inactivating mutations of the FSH receptor (Tapanainen et al, 1997) , quantitatively normal spermatogenesis in men appears to require both gonado¬ trophins (Matsumoto et al, 1986) . Possible reasons for the lack of consensus include differences between species, the specifics of the experimental paradigms and the approaches used to describe changes in germ cell development. et al, 1991) provides a means of assessing the effects of hormonal treatments for developing human contraceptive strategies (for example, using GnRH analogues) and for design¬ ing interventions aimed at protecting spermatogenesis from radio-chemotherapeutic damage (Kangasniemi et al, 1995) .
Exogenous testosterone treatment, with or without co-administration of a GnRH antagonist (GnRH-A), is a promising male contraceptive strategy; however, the inconsist¬ ent induction of azoospermia has not been explained and may limit its widespread application (Bagatell et al, 1993;  WHO, 1990 ; Andersen and Wu, 1996) . Furthermore, the site(s) of spermatogenic interruption during such treatment has not been well described.
Previous studies aimed at defining the site of spermatogenic interruption after gonadotrophin withdrawal in primates have been limited in number and have used either qualitative descriptions of the disruption of spermatogenesis or quantita¬ tive approaches based on older methods subject to bias. This bias derives from the need to make assumptions regarding the shape and size of the nuclei, and the failure to account for changes in the size of the reference compartments (for example, interstitium and tubules). Such assumptions are inevitable when expressing germ cell number in terms of a two-dimensional parameter such as per Sertoli cell nuclear profile or per tubule cross-section. The stereological literature provides the scientific basis for appreciating the origins of bias in earlier approaches (Sterio, 1984; Gundersen et al, 1988a; Wreford, 1995 (Wreford, 1995 (Adams et al, 1986; Weinbauer et al, 1991 Weinbauer et al, , 1992 Weinbauer et al, , 1994 . In animals treated with GnRH-A for weeks, the number of pachytene spermatocytes and spermatids declined markedly until only Sertoli cells, spermatogonia and few, if any, later germ cell forms were seen (Akhtar et al, 1985; Adams et al, 1986; Weinbauer et al, 1987 Weinbauer et al, , 1988 Weinbauer et al, , 1991 (Clermont and Leblond, 1955, 1959; Clermont, 1969 (Sterio, 1984; Gundersen et al, 1988a) . Wreford (1995) (1955, 1959 (Baddeley et al, 1986) according to the unbiased and efficient stereo¬ logical principle of the rotator (Jensen and Gundersen, 1993) . Forty Sertoli cell nuclei were sampled (from the vertical segment of the seminiferous tubule using the optical disector; Sterio, 1984) (Fig. 4) . The dynamics of spermatogenic regression after GnRH-A treatment in the present study are consistent with the inhibition of division of Ap spermatogonia. According to the model of the primate seminiferous cycle (Clermont, 1969; Clermont and Antar, 1973; Fouquet and Dadoune, 1986) (Andersen and Wu, 1996) (Sharpe, 1994; McLachlan et al, 1996) . In contrast, in GnRH-A-treated rats, testicular testosterone concentrations fall more quickly and markedly (Sinha-Hikim and Swerdloff, 1993) 
